Healthcare Sector

ABBV

Market Tracker

$217.40
-10.80
(-4.73%)
6:23 pm
Next Earnings: (est.) 07/27/23 12:00 am
  • ABBV (Selected)

    AbbVie Inc.

ABBV Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

ABBV Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ABBV Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ABBV Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

ABBV Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ABBV Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
10/31/2025 PUT $210.00 4,398 +3,830 +674.30%
11/07/2025 CALL $230.00 2,713 +2,478 +1,054.47%
11/07/2025 CALL $240.00 2,696 +2,163 +405.82%
10/31/2025 PUT $217.50 5,060 +1,002 +24.69%
11/07/2025 PUT $222.50 710 +696 +4,971.43%
10/31/2025 PUT $215.00 1,212 +549 +82.81%
03/20/2026 PUT $175.00 465 -64 -12.10%
10/31/2025 CALL $232.50 636 -72 -10.17%
02/20/2026 CALL $200.00 134 -93 -40.97%
01/15/2027 CALL $150.00 157 -127 -44.72%
01/16/2026 PUT $230.00 857 -136 -13.70%
12/19/2025 CALL $240.00 13,289 -747 -5.32%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ABBV Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 53.76M 7.26B
Vanguard 500 Index Fund 2.32% 40.88M 5.52B
Fidelity 500 Index Fund 1.10% 19.39M 2.62B
SPDR S&P 500 ETF Trust 1.09% 19.15M 2.58B
American Mutual Fund Inc 1.00% 17.6M 2.38B
iShares Core S&P 500 ETF 0.89% 15.78M 2.13B
Vanguard Index-Value Index Fund 0.87% 15.28M 2.06B
Capital Income Builder, Inc. 0.84% 14.87M 2.01B
Select Sector SPDR Fund-Health Care 0.81% 14.36M 1.94B
Washington Mutual Investors Fund 0.75% 13.22M 1.78B

ABBV News

  • AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

    10/31 11:47 am

    Benzinga

    Read more
  • Anti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility

    10/31 11:00 am

    GlobeNewswire Inc.

    Read more
  • Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025

    10/31 02:35 am

    GlobeNewswire Inc.

    Read more
  • Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

    10/28 08:27 am

    The Motley Fool

    Read more
  • Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?

    10/28 06:26 am

    The Motley Fool

    Read more
  • Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade

    10/26 11:21 am

    The Motley Fool

    Read more
  • AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth

    10/23 01:07 pm

    The Motley Fool

    Read more
  • Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock

    10/23 10:33 am

    The Motley Fool

    Read more
  • Abacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market

    10/21 03:12 pm

    The Motley Fool

    Read more
  • Global Liquid Filters Market to Reach US$ 26.5 Billion by 2033 | Astute Analytica

    10/20 12:30 pm

    GlobeNewswire Inc.

    Read more
  • 3 Dividend-Paying ETFs to Double Down On Even if the S&P 500 Sells Off in October

    10/20 08:21 am

    The Motley Fool

    Read more
  • OSE Immunotherapeutics Reports First Half 2025 Financial Results

    10/15 01:00 pm

    GlobeNewswire Inc.

    Read more
  • OSE Immunotherapeutics publie ses résultats financiers du 1er semestre 2025

    10/15 01:00 pm

    GlobeNewswire Inc.

    Read more
  • The Best Dividend ETF to Invest $500 in Right Now

    10/14 04:15 am

    The Motley Fool

    Read more
  • The Best Dividend ETF to Invest $1,000 in Right Now

    10/12 01:05 pm

    The Motley Fool

    Read more
  • Aesthetics Market to Reach USD 148.27 Billion by 2033, Driven by Surge in Minimally Invasive Procedures and Global Cosmetic Innovation – SNS Insider

    10/10 10:00 am

    GlobeNewswire Inc.

    Read more
  • Higher Levels of Trust Determine 2025 Fortune 100 Best Companies to Work For Europe

    10/09 03:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Exceptional Stocks to Build Long-Term Wealth

    10/08 01:23 pm

    Investing.com

    Read more
  • Why AbbVie Stock Cruised to an Almost 6% Gain Today

    10/01 06:36 pm

    The Motley Fool

    Read more
  • Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

    10/01 05:25 am

    The Motley Fool

    Read more
  • Want Decades of Passive Income? Buy This Index Fund and Hold It Forever

    09/29 09:33 pm

    The Motley Fool

    Read more
  • Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

    09/29 07:30 pm

    GlobeNewswire Inc.

    Read more
  • Fc and Glycoengineered Antibodies Market Report 2025: Antibody Therapeutics Surge with 550+ Clinical Pipeline Molecules - Fc Innovations Leading the Charge

    09/23 10:59 am

    GlobeNewswire Inc.

    Read more
  • Topical Drugs CDMO Market Size to Expand USD 136.71 Billion by 2034

    09/18 11:00 am

    GlobeNewswire Inc.

    Read more
  • Barrett's Esophagus Strategic Business Report 2025-2030 Featuring 34 Companies - Innovative Diagnostics and Therapies Propel Market Growth

    09/15 05:56 am

    GlobeNewswire Inc.

    Read more
  • 1 Green Flag for AbbVie (ABBV) Stock Right Now

    09/12 01:30 pm

    The Motley Fool

    Read more
  • Meet the Vanguard ETF That Yields More Than Twice the S&P 500 Average and Has Minimal Fees

    09/12 05:10 am

    The Motley Fool

    Read more
  • Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

    09/11 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Why This Dividend ETF is Perfectly Balanced for Yield and Growth

    09/10 06:23 am

    The Motley Fool

    Read more
  • The Schwab U.S. Dividend Equity ETF (SCHD) Is One of the Leading Blue Chip ETFs in 2025. Here's Why.

    09/09 09:30 am

    The Motley Fool

    Read more
  • Should Passive Income Investors Be Concerned That 54% of the High-Yield Schwab U.S. Dividend Equity ETF Is in Just 3 Stock Market Sectors?

    09/08 06:27 am

    The Motley Fool

    Read more
  • AbbVie Declares Quarterly Dividend

    09/05 09:07 am

    Benzinga

    Read more
  • Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?

    09/04 04:09 am

    The Motley Fool

    Read more
  • Multiple Myeloma Market Size Projected USD 49.89 Billion by 2034

    09/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Healthcare Valuations Near Multi-Year Lows Suggest Risk–Reward Asymmetry

    09/02 09:37 am

    Investing.com

    Read more
  • Deal Dispatch: PepsiCo, Sycamore, Dr. Phil, SSENSE, Bain's Chindata Lead M&A, Bankruptcy Moves

    08/29 03:20 pm

    Benzinga

    Read more
  • Dermatology Market to Worth USD 2.75 Billion Size by 2034

    08/29 11:00 am

    GlobeNewswire Inc.

    Read more
  • As the Market Rotates, This Healthcare ETF Is Leading the Way

    08/26 10:07 am

    Investing.com

    Read more
  • AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment

    08/26 09:26 am

    Benzinga

    Read more
  • Viking Therapeutics: What's Next?

    08/26 06:15 am

    The Motley Fool

    Read more
  • 3 Top Stocks to Build Your Portfolio Around

    08/24 09:15 am

    The Motley Fool

    Read more
  • Global Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032 | DelveInsight

    08/21 01:00 pm

    GlobeNewswire Inc.

    Read more
  • AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib

    08/21 10:10 am

    Benzinga

    Read more
  • Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing

    08/20 10:00 am

    GlobeNewswire Inc.

    Read more
  • Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030

    08/19 01:54 pm

    GlobeNewswire Inc.

    Read more
  • Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

    08/14 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Autoinjectors Market Set to Surpass USD 3.02 Billion by 2030 as Demand for Advanced Drug Delivery Systems Accelerates | MarketsandMarkets™.

    08/12 08:00 am

    GlobeNewswire Inc.

    Read more
  • AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules

    08/08 02:00 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: